Drugs / HER-2/neu Pulsed DC1 vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT02473653 | — | metastatic malignant neoplasm | University of Pennsylvania | No longer available | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HER-2/neu Pulsed DC1 vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02473653 ↗ |
| Modality | Vaccine | “One form of such therapy is the dendritic cell combined with HER-2/neu (a type of protein over-expressed in some cancers) vaccine.” NCT02473653 ↗ |